High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice
Although improvements in technology for the isolation of potential therapeutic antibodies have made the process increasingly predictable, the development of biologically active monoclonal antibodies (mAbs) into drugs can often be impeded by developability issues such as poor expression, solubility,...
Main Authors: | , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Landes Bioscience
2016
|
Online Access: | http://hdl.handle.net/1721.1/101373 https://orcid.org/0000-0003-2398-5896 https://orcid.org/0000-0001-5003-9104 |